Weak China numbers send US dollar higher to detriment of metals
Support for legislation enabling unexplained wealth to be probed is to be welcomed
But advocate Mpofu says justices must accept former prisons chief granted parole correctly
Provincial chair elect indicates he will support Ramaphosa’s re-election as ANC president
Capital reserves of R124bn will help shield bank against a possible global economic downturn
Consumer finances crumble under the pressure of rising prices and interest rates, Unisa vulnerability report shows
Some in the industry believe a ban on the export of scrap will mean a more competitive steel industry, with lower prices passed on to consumers
Washington targets chief of staff Nathaniel McGill, chief prosecutor Sayma Syrenius Cephus and Bill Twehway, MD of Liberia’s National Port Authority
Veteran seamer believes he still has plenty to offer despite turning 40
Demographics paint a gloomy picture for continued US dominance, until one looks at the Chinese figures, argues Niall Ferguson
When Covid-19 first became pandemic, one of the immediate challenges was to develop a safe and effective vaccine to prevent if not infection then at least illness and especially severe illness. Such vaccines were developed in record time. The challenge then shifted to rolling out those vaccines to the world’s population. At a global level, meeting this challenge, far from breaking any records, has been a colossal failure. The vaccines have reached only a small proportion of the people who want and should have them.
Those countries that have had some success in vaccinating their populations now face a subsidiary rollout challenge — getting the vaccine into enough of those people who are resistant to or hesitant about being vaccinated (whether in general or against Covid-19 in particular)...
If you have already registered or subscribed, please sign in to continue.
Questions or problems? Email firstname.lastname@example.org or call 0860 52 52 00.
Would you like to comment on this article? Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.